The analysis of H2B family gene expression in glioma showed that H2BC5, H2BC9, H2BC11, and H2BC21 can be used as independent predictive factors for glioma prognosis, and overexpression of H2BC9 and H2BC11 may lead to tumor deterioration through the immune system. This evidence concerns the gene H2BC11 and central nervous system cancer.